Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Lily Hillson"'
Autor:
Kathryn A. Pennel, Phimmada Hathakarnkul, Sara S. Al-Badran, Umar Hashmi, Lily Hillson, Jean A. Quinn, Leia Jones, Colin W. Steele, Donald C. McMillan, James H. Park, Owen J. Sansom, Joanna Birch, Campbell S. Roxburgh
Publikováno v:
Cancer Research. 83:1080-1080
Background: Rectal cancer (RC) remains a leading cause of cancer-related mortality worldwide. Despite existing therapeutics such as neoadjuvant radiotherapy, 5-year survival outcomes remain low at ~60%. Rectal tumors are heterogeneous and underpinned
Autor:
Liyam Laraba, Lily Hillson, Julio Grimm de Guibert, Amy Hewitt, Maisie R Jaques, Tracy T Tang, Leonard Post, Emanuela Ercolano, Ganesha Rai, Shyh-Ming Yang, Daniel J Jagger, Waldemar Woznica, Philip Edwards, Aditya G Shivane, C Oliver Hanemann, David B Parkinson
Publikováno v:
Brain : a journal of neurology.
Schwannoma tumours typically arise on the eighth cranial nerve and are mostly caused by loss of the tumour suppressor Merlin (NF2). There are no approved chemotherapies for these tumours and the surgical removal of the tumour carries a high risk of d
Autor:
Campbell SD Roxburgh, Catherine Ruth Hanna, Janet Graham, Mark P. Saunders, Leslie M. Samuel, Nicholas James MacLeod, Lynsey Devlin, Joanne Edwards, Lily Hillson, Ross K McMahon, Leia Ashleigh Jones, Caroline Kelly, Liz-Anne Lewsley, Paula Morrison, Peter Atherton, Nicola Walker, Jacqueline Gourlay, Ellie Tiplady, Richard Adams, Sean Michael O'Cathail
Publikováno v:
Journal of Clinical Oncology. 40:TPS231-TPS231
TPS282 Background: Advances in multi-modality treatment of locally advanced rectal cancer (LARC) have resulted in low local recurrence rates, but many patients still die from distant disease. There is increasing recognition that with neoadjuvant trea
Autor:
Lily Hillson, David Parkinson, Natalia J. Martinez, Aditya G. Shivane, Ganesha Rai Bantukallu, Shyh-Ming Yang, Anton Simeonov, Liyam Laraba, Philip Edwards
Publikováno v:
Cancer Research. 80:5957-5957
Our lab is interested in the development and growth of schwannoma and meningioma tumors of the nervous system. Approximately 70% of these tumors arise due to loss of the tumor suppressor Merlin. In a mouse model of schwannoma (P0-CRE NF2fl/fl), we ob